Assoc. Prof. Dr. Xiaoning wang, Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, China
Dr. Xiaoning Wang serves as the Deputy Director at The First Affiliated Hospital of Xi’an Jiaotong University. With over 17 years of medical expertise, Dr. Wang is an Associate Chief Physician specializing in hematopoietic stem cell transplantation and immunotherapy. š§¬āØ He has led notable research projects, including advancements in acute T-cell leukemia treatment and NK cell reconstruction. Dr. Wang has published extensively in renowned journals like Blood and Nature Communications š©øš and holds multiple patents. A leader in the field, he is a key figure in various medical associations, driving innovation and collaboration in hematology. šš
Publication Profile
Orcid
Academic and Professional Background šš¼
Assoc. Prof. Dr. Xiaoning Wang has a rich medical career spanning over 17 years. He currently serves as an Associate Chief Physician (Jan 2017 – Present), where he oversees advanced hematology treatments and research. Previously, he worked as an Attending Physician (Mar 2012 – Dec 2016), gaining extensive expertise in patient care and clinical decision-making. His medical journey began as a Resident Doctor (July 2006 – Feb 2012), where he honed his foundational skills in diagnostics and treatment. Dr. Wangās professional growth reflects his dedication to medical excellence and patient-focused innovation. š„š©ŗāØ
Research Contributions
Assoc. Prof. Dr. Xiaoning Wang is a prominent researcher whose work spans hematology, oncology, and infectious diseases. Key studies include identifying the novel HLA-C*14:02:01:33 allele via advanced sequencing techniques, optimizing treatment regimens for severe pneumocystis pneumonia, and investigating high NK cell levels in grafts reducing febrile neutropenia post-transplantation. Her pivotal work on molecular biomarkers in multiple myeloma and graft-versus-host disease therapies showcases her innovative approach to immunology and stem cell research. Dr. Wang has significantly contributed to international medical knowledge, with publications in Nature Communications, Blood, and JAMA Ophthalmology. šāØ
Publication Top NotesĀ 
- The novel HLA-C*14:02:01:33 allele identified by Pacific Biosciences HiFi sequencing in a Chinese individual.
- A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
- Endogenous Aspergillus thermomutatus Endophthalmitis in a Patient With Myelodysplastic Syndrome.
- High levels of NK Cells in graft are associated with reduced febrile neutropenia after haploidentical peripheral blood stem cell transplantation.
- The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients.
- Bloody tears as initial manifestation of rhino-orbital mucormycosis.
- Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case report.
- ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
- Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report.
- Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.